Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease.
Researchers identify how vector-borne diseases in different environments respond to human pressures.
Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
A trio of emerging Griffith University health scientists have been named as Queensland Young Tall Poppies for 2021.
Griffith University’s Institute for Glycomics celebrates the promotion of six of its researchers, in recognition of their outstanding contributions to...
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at...
Griffith University has been named as a Global Virus Network Centre of Excellence, one of three in Australia.
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
A new Griffith University study aims to develop drugs to treat alphavirus infection such as Ross River, Chikungunya, O’nyong’nyong and...
